Skip to main content

Jury Awards $13M To Mesothelioma Victim’s Family

Jury Awards $13M To Mesothelioma Victim’s Family

Jury Awards $13M To Mesothelioma Victim’s Family

Introduction

Last week, a California appellate court declared the $13 million verdict made by a lower court jury in favor of a mesothelioma victim's family.

According to the court memorandum, the victim was affected by the rare and deadly asbestos-related disease while growing up in the company town of Betteravia, California. The victim's father, as well as grandfather, worked at Hillshire Brands, a Tyson Foods subsidiary, where they were exposed to asbestos.

The lawsuit alleges that the carcinogenic material was brought into the family's home on the hair, skin, and clothing of his father and grandfather as the company did not provide safety precautions to protect either workers or their families from asbestos. The victim died due to mesothelioma in 2015.

The lower court jury had awarded the victim's family $2 million in economic damages and $11 million in non-economic damages, which was appealed by the defendants for inadequate evidence. The assertion was later denied by the appellate court.

Asbestos is one of the main ingredients in baby powder, considered cosmetic when used in makeup and body powders, which require very little federal oversight. The U.S. Food and Drug Administration (FDA) is alerting consumers about certain cosmetic products due to the presence of asbestos. Despite several studies highlighting the cancer risk, the FDA does not require Baby Powder warnings on talc-based product labels to be updated. Moreover, J&J has also refused to add one, willingly.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!